Yujia Kong

Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial

Hongyan Cheng, Liju Zong, Yujia Kong et al. · The Lancet Oncology · 2021 · 82 citations

Medicine, Oncology, Chemotherapy +9

Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study

Yujia Kong, Junjun Yang, Fang Jiang et al. · Gynecologic Oncology · 2017 · 51 citations · Full text

Medicine, Gynecology, Obstetrics +10

<p>Cervical cancer in women aged 25 years or younger: a retrospective study</p>

Yujia Kong, Liju Zong, Junjun Yang et al. · Cancer Management and Research · 2019 · 39 citations · Full text

Medicine, Oncology, Surgery +17

The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery

Liju Zong, Qianqian Zhang, Yujia Kong et al. · Gynecologic Oncology · 2019 · 30 citations

Medicine, Oncology, Surgery +10

Management and risk factors of recurrent gestational trophoblastic neoplasia: An update from 2004 to 2017

Yujia Kong, Liju Zong, Hongyan Cheng et al. · Cancer Medicine · 2020 · 28 citations · Full text

Medicine, Gynecology, Oncology +13